CRP and cardiovascular disorder: A retrospective study of 539 testicular survivals showed that patients with CRP ≥ 1.5 mg/L had a larger risk of developing a non-germ cell second tumor and a higher risk of cardiovascular disease than survivors with CRP<1.5 mg/L.